The Effects of Midazolam on the Quality of Postoperative Recovery

NCT ID: NCT01993459

Last Updated: 2016-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

192 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether Midazolam given pre-operatively to patients undergoing abdominal surgery improves the quality of recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Period Anxiety Fatigue Depression Aggression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Midazolam intravenous

3mg/ml midazolam given intravenously

Group Type EXPERIMENTAL

Midazolam

Intervention Type DRUG

We will administer Midazolam 3mg intravenously once pre-operatively to patients just before they undergo surgery

NaCl (sodium chloride) 0,9%

NaCl (sodium chloride) 0,9% given intravenously 3ml.

Group Type PLACEBO_COMPARATOR

NaCl (sodium chloride) 0,9%

Intervention Type DRUG

We will administer NaCl (sodium chloride) 0,9% 3ml intravenously once pre-operatively to patients just before they undergo surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Midazolam

We will administer Midazolam 3mg intravenously once pre-operatively to patients just before they undergo surgery

Intervention Type DRUG

NaCl (sodium chloride) 0,9%

We will administer NaCl (sodium chloride) 0,9% 3ml intravenously once pre-operatively to patients just before they undergo surgery

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Dormicum saline solution sodium chloride solution

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patiënts operated with a laparotomy in the Erasmus Medical Center of Rotterdam, older than 18 years and planned for a postoperative stay for a minimum of 3 days

Exclusion Criteria

* Pregnant, benzodiazepine usage, contra-indication for midazolam, mental retardation, non-dutch speaking patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erasmus Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stefan van Beek

BSc

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Jan Stolker, MD, PhD

Role: STUDY_CHAIR

Erasmus MC Rotterdam Anesthesiology

Markus Klimek, MD, PhD

Role: STUDY_CHAIR

Erasmus MC Rotterdam Anesthesiology

Stefan van Beek, BSc

Role: PRINCIPAL_INVESTIGATOR

Erasmus MC Rotterdam Anesthesiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erasmus Medical Centre

Rotterdam, South Holland, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

References

Explore related publications, articles, or registry entries linked to this study.

van Beek S, Kroon J, Rijs K, Mijderwijk HJ, Klimek M, Stolker RJ. The effect of midazolam as premedication on the quality of postoperative recovery after laparotomy: a randomized clinical trial. Can J Anaesth. 2020 Jan;67(1):32-41. doi: 10.1007/s12630-019-01494-6. Epub 2019 Oct 1.

Reference Type DERIVED
PMID: 31576513 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14091991

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.